Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2022 ∙ Rahmig, J. Altarsha, E. Siepmann, T. Barlinn, K.
Acute Ischemic Stroke in the Context of SARS-CoV-2 Vaccination: A Systematic Review
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Daly, S. Nguyen, A. V. Soto, J. M. Vance, A. Z.
Ad26.COV2.S Vaccine-Induced Thrombocytopenia Leading to Dural Sinus Thrombosis and Intracranial Hemorrhage Requiring Hemicraniectomy: A Case Report and Systematic Review
All age groups COVID-19 Safety
Rating:
Critically low
2022 ∙ Pischel, L. Patel, K. M. Goshua, G. Omer, S. B.
Adenovirus-based vaccines and thrombosis in pregnancy: A systematic review and meta-analysis
Pregnant women COVID-19 Safety
Rating:
Critically low
2022 ∙ Bai, X. Chen, L. Liu, X. Tong, Y. Wang, L. Zhou, M. Li, Y. Hu, G.
Adult Hepatitis B Virus Vaccination Coverage in China from 2011 to 2021: A Systematic Review
Western Pacific China All age groups Hepatitis B Coverage
Rating:
Not applicable
2022 ∙ Wu, X. Yang, H. He, S. Xia, T. Chen, D. Zhou, Y. Liu, J. Liu, M. Sun, Z.
Adult Vaccination as a Protective Factor for Dementia: A Meta-Analysis and Systematic Review of Population-Based Observational Studies
Adults Older adults Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Villavicencio, A. Ebisu, Y. Raja, M. Sanchez-Covarrubias, A. P. Reynolds, J. M. Natori, Y.
Adverse events after SARS-CoV-2 vaccination in solid organ transplant recipients: A systematic review
All age groups COVID-19 Safety
Rating:
Critically low
2022 ∙ Kouhpayeh, Hamidreza Ansari, Hossein
Adverse Events Following COVID-19 Vaccination: A Systematic Review and Meta-analysis
All age groups COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Alhossan, A. Alsaran, A. K. Almahmudi, A. H. Aljohani, Z. S. Albishi, M. R. Almutairi, A. K.
Adverse Events of COVID-19 Vaccination among the Saudi Population: A Systematic Review and Meta-Analysis
Eastern Mediterranean Saudi Arabia Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Samim, M. M. Dhar, D. Goyal, S. Dey, T. Parvin, N. Shah, R. D. Singh, V. Chowdhury, S. Lal, B. M. Varghese, N. Gohel, A. Chowdhury, A. Chatterjee, A. Siddiqui, S.
AI-CoV Study: Autoimmune Encephalitis Associated With COVID-19 and Its Vaccines-A Systematic Review
Adolescents Adults COVID-19 Safety
Rating:
Low
2022 ∙ Krauss, S. R. Barbateskovic, M. Klingenberg, S. L. Djurisic, S. Petersen, S. B. Kenfelt, M. Kong, D. Z. Jakobsen, J. C. Gluud, C.
Aluminium adjuvants versus placebo or no intervention in vaccine randomised clinical trials: A systematic review with meta-analysis and Trial Sequential Analysis
All age groups Efficacy/effectiveness Safety
Rating:
Critically low
Loading...